Richard P. Valencia Purchases 1,300 Shares of Tandem Diabetes Care Inc (TNDM) Stock

Share on StockTwits

Tandem Diabetes Care Inc (NASDAQ:TNDM) Director Richard P. Valencia bought 1,300 shares of the stock in a transaction that occurred on Monday, November 5th. The stock was acquired at an average price of $37.75 per share, for a total transaction of $49,075.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Shares of TNDM stock opened at $38.40 on Friday. Tandem Diabetes Care Inc has a 52-week low of $2.14 and a 52-week high of $52.55. The stock has a market capitalization of $2.11 billion, a price-to-earnings ratio of -2.98 and a beta of 0.53.

Tandem Diabetes Care (NASDAQ:TNDM) last issued its quarterly earnings data on Thursday, November 1st. The medical device company reported ($0.62) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.34) by ($0.28). Tandem Diabetes Care had a negative return on equity of 204.32% and a negative net margin of 93.07%. The firm had revenue of $46.30 million during the quarter, compared to the consensus estimate of $42.71 million. During the same period in the previous year, the company posted ($3.09) earnings per share. The company’s revenue for the quarter was up 71.5% on a year-over-year basis. On average, equities analysts predict that Tandem Diabetes Care Inc will post -1.35 earnings per share for the current fiscal year.

Hedge funds have recently modified their holdings of the business. US Bancorp DE grew its position in Tandem Diabetes Care by 397.8% in the 3rd quarter. US Bancorp DE now owns 2,489 shares of the medical device company’s stock worth $107,000 after purchasing an additional 1,989 shares in the last quarter. Meeder Asset Management Inc. grew its position in Tandem Diabetes Care by 1,921.6% in the 3rd quarter. Meeder Asset Management Inc. now owns 2,709 shares of the medical device company’s stock worth $116,000 after purchasing an additional 2,575 shares in the last quarter. Legal & General Group Plc bought a new stake in Tandem Diabetes Care in the 2nd quarter worth about $147,000. Gilder Gagnon Howe & Co. LLC bought a new stake in Tandem Diabetes Care in the 3rd quarter worth about $174,000. Finally, A.R.T. Advisors LLC grew its position in Tandem Diabetes Care by 284.4% in the 1st quarter. A.R.T. Advisors LLC now owns 38,518 shares of the medical device company’s stock worth $191,000 after purchasing an additional 28,499 shares in the last quarter. 62.80% of the stock is owned by institutional investors and hedge funds.

TNDM has been the topic of a number of analyst reports. Robert W. Baird restated a “buy” rating and issued a $31.00 target price on shares of Tandem Diabetes Care in a report on Monday, July 23rd. Cowen restated a “buy” rating and issued a $28.00 target price on shares of Tandem Diabetes Care in a report on Tuesday, July 31st. Stifel Nicolaus restated a “hold” rating and issued a $25.00 target price (up previously from $7.50) on shares of Tandem Diabetes Care in a report on Tuesday, July 31st. Piper Jaffray Companies upped their target price on shares of Tandem Diabetes Care to $32.00 and gave the stock an “overweight” rating in a report on Tuesday, July 31st. Finally, Lake Street Capital upped their target price on shares of Tandem Diabetes Care to $35.00 and gave the stock a “buy” rating in a report on Tuesday, July 31st. Four analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. Tandem Diabetes Care currently has an average rating of “Buy” and a consensus target price of $44.27.

TRADEMARK VIOLATION WARNING: “Richard P. Valencia Purchases 1,300 Shares of Tandem Diabetes Care Inc (TNDM) Stock” was originally published by Macon Daily and is the property of of Macon Daily. If you are reading this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this piece of content can be viewed at https://macondaily.com/2018/11/09/richard-p-valencia-purchases-1300-shares-of-tandem-diabetes-care-inc-tndm-stock.html.

Tandem Diabetes Care Company Profile

Tandem Diabetes Care, Inc, a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set.

Featured Story: Is the Dow Jones Industrial Average (DJIA) still relevant?

Receive News & Ratings for Tandem Diabetes Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tandem Diabetes Care and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply